UM1DA058219
Cooperative Agreement
Overview
Grant Description
WashU-VAI Somatic Mosaicism Across Human Tissues (SMAHT) Program Genome Characterization Center - Project Summary
The Somatic Mosaicism Across Human Tissues (SMAHT) network aims to propel the discovery of new biological processes in human health and disease that are mediated by genomic variation in somatic tissues. We propose to establish the WashU-VAI Somatic Mosaicism Across Human Tissues (SMAHT) Program Genome Characterization Center (SMAHT-GCC).
A fundamental goal of our proposed GCC is to generate high throughput, high quality, and high consistency genomic DNA and RNA sequencing data, and to construct a comprehensive catalogue of human somatic variation together with other members of the network.
First, we will establish and manage a collaborative, efficient, transparent, and flexible GCC as an integral component of the SMAHT network. We will leverage our experience in participating and leading many past and current genomics consortia to design and implement our GCC. The GCC will manage center administration, maintain high quality, sustainable, and on-time data production, develop and implement data management plans, conduct data quality assurance and integrative data analysis, and fully engage with the entire SMAHT network.
Second, we will generate high quality, high throughput, comprehensive, and sustainable genomics datasets for the characterization of human somatic mosaicism, using state-of-the-art technologies. We capitalize on our past experience in generating high quality sequencing-based genomic resources to design and implement our data production plan. We recommend a collection of human tissue types and will implement four core genomics assays to profile samples received from the SMAHT Tissue Procurement Center. We aim to deliver high throughput, high quality, and high consistency genomic DNA and RNA sequencing data to the SMAHT Data Analysis Center.
Third, we will develop and maintain a modern, efficient, scalable, and interactive data management and processing system that seamlessly interfaces with the SMAHT Data Analysis Center. We will leverage our experience in scientific computing, information technology systems, large genomic data management and integration, and community engagement to design and implement our data management plan. We will build a streamlined, efficient data infrastructure to manage GCC data and collaborate with SMAHT DAC.
Fourth, we will develop and implement data analysis and visualization solutions for the SMAHT-GCC data. We will leverage our extensive experience in genomic data analysis and integration, bioinformatics tool development, as well as data visualization in the implementation of our data analysis and visualization plan. We will also bring in unique expertise in analyzing transposable elements and epigenomics data. We will contribute to the network-wide data analysis and facilitate the characterization of a full spectrum of human somatic mosaicism.
The Somatic Mosaicism Across Human Tissues (SMAHT) network aims to propel the discovery of new biological processes in human health and disease that are mediated by genomic variation in somatic tissues. We propose to establish the WashU-VAI Somatic Mosaicism Across Human Tissues (SMAHT) Program Genome Characterization Center (SMAHT-GCC).
A fundamental goal of our proposed GCC is to generate high throughput, high quality, and high consistency genomic DNA and RNA sequencing data, and to construct a comprehensive catalogue of human somatic variation together with other members of the network.
First, we will establish and manage a collaborative, efficient, transparent, and flexible GCC as an integral component of the SMAHT network. We will leverage our experience in participating and leading many past and current genomics consortia to design and implement our GCC. The GCC will manage center administration, maintain high quality, sustainable, and on-time data production, develop and implement data management plans, conduct data quality assurance and integrative data analysis, and fully engage with the entire SMAHT network.
Second, we will generate high quality, high throughput, comprehensive, and sustainable genomics datasets for the characterization of human somatic mosaicism, using state-of-the-art technologies. We capitalize on our past experience in generating high quality sequencing-based genomic resources to design and implement our data production plan. We recommend a collection of human tissue types and will implement four core genomics assays to profile samples received from the SMAHT Tissue Procurement Center. We aim to deliver high throughput, high quality, and high consistency genomic DNA and RNA sequencing data to the SMAHT Data Analysis Center.
Third, we will develop and maintain a modern, efficient, scalable, and interactive data management and processing system that seamlessly interfaces with the SMAHT Data Analysis Center. We will leverage our experience in scientific computing, information technology systems, large genomic data management and integration, and community engagement to design and implement our data management plan. We will build a streamlined, efficient data infrastructure to manage GCC data and collaborate with SMAHT DAC.
Fourth, we will develop and implement data analysis and visualization solutions for the SMAHT-GCC data. We will leverage our extensive experience in genomic data analysis and integration, bioinformatics tool development, as well as data visualization in the implementation of our data analysis and visualization plan. We will also bring in unique expertise in analyzing transposable elements and epigenomics data. We will contribute to the network-wide data analysis and facilitate the characterization of a full spectrum of human somatic mosaicism.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Place of Performance
Saint Louis,
Missouri
631101010
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 386% from $2,500,000 to $12,145,211.
Washington University was awarded
SMAHT Genome Characterization Center: Advancing Human Somatic Mosaicism Research
Cooperative Agreement UM1DA058219
worth $12,145,211
from the National Institute of Allergy and Infectious Diseases in May 2023 with work to be completed primarily in Saint Louis Missouri United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.310 Trans-NIH Research Support.
The Cooperative Agreement was awarded through grant opportunity Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional).
Status
(Ongoing)
Last Modified 8/6/25
Period of Performance
5/1/23
Start Date
4/30/28
End Date
Funding Split
$12.1M
Federal Obligation
$0.0
Non-Federal Obligation
$12.1M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for UM1DA058219
Transaction History
Modifications to UM1DA058219
Additional Detail
Award ID FAIN
UM1DA058219
SAI Number
UM1DA058219-3801678875
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75N600 NIH National Insitute on Drug Abuse
Funding Office
75NA00 NIH OFFICE OF THE DIRECTOR
Awardee UEI
L6NFUM28LQM5
Awardee CAGE
2B003
Performance District
MO-01
Senators
Joshua Hawley
Eric Schmitt
Eric Schmitt
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
Office of the Director, National Institutes of Health, Health and Human Services (075-0846) | Health research and training | Grants, subsidies, and contributions (41.0) | $2,654,677 | 100% |
Modified: 8/6/25